Horizon Scanning in Oncology – Prioritisation of new and emerging oncologic drugs

Within the project Horizon Scanning in Oncology new/emerging oncologic drugs were identified and prioritised by an expert panel to identify those therapies for which either a substantial clinical or financial impact can be expected.

HSO Priorisation No. 41

HSO Priorisation No. 40

HSO Priorisation No. 39

HSO Priorisation No. 38

HSO Priorisation No. 37

HSO Priorisation No. 36

HSO Priorisation No. 35

HSO Priorisation No. 34

HSO Priorisation No. 33

HSO Priorisation No. 32

HSO Priorisation No. 31

HSO Priorisation No. 30

HSO Priorisation No. 29

HSO Priorisation No. 28

HSO Priorisation No. 27

HSO Priorisation No. 26

HSO Priorisation No. 25

HSO Priorisation No. 24

HSO Priorisation No. 23

HSO Priorisation No. 22

HSO Priorisation No. 21

HSO Priorisation No. 20

HSO Priorisation No. 19

HSO Priorisation No. 18